A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

Mise à jour : Il y a 4 ans
Référence : NCT01125514

Femme et Homme

Extrait

This study assessed the interaction between single and multiple doses of aliskiren (150 mg and 300 mg) and furosemide (60 mg) in patients with heart failure.


Critère d'inclusion

  • Heart failure

Liens